Furthermore, global DNA hypermethylation seen in gastrointestinal stromal tumor (GIST) patients leads to recurrent loss of CTCF binding in the boundary between ANO1 and the FGF genes, and higher levels of FGF activity (Flavahan et al., 2019). This evidence concerns the gene CTCF and gastrointestinal stromal tumor.